Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results.1 passage
• (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis.1 passage
• (untitled)1 passage
• 15-Deoxy-Δ12,14-Prostaglandin J1 passage
• 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G1 passage
• A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases.1 passage
• A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.1 passage
• A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.1 passage
• A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.1 passage
• A Mutation in the G-Protein Gene1 passage
• A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.1 passage
• A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction.1 passage
• A New Therapeutic Framework for Atrial Fibrillation Drug Development.1 passage
• A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.1 passage
• A Novel Regulatory Mechanism of Smooth Muscle α-Actin Expression by NRG-1/circACTA2/miR-548f-5p Axis.1 passage
• A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells.1 passage
• A Path Forward for Regenerative Medicine.1 passage
• A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.1 passage
• A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio.1 passage
• A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.1 passage
• A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.1 passage
• A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.1 passage
• ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.1 passage
• AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling.1 passage
• AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System.1 passage
• ARHGAP18 Protects Against Thoracic Aortic Aneurysm Formation by Mitigating the Synthetic and Proinflammatory Smooth Muscle Cell Phenotype.1 passage
• ATAC-Seq Reveals an1 passage
• ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart.1 passage
• AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus.1 passage
• Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.1 passage
• Abstract MP265: The Role Of Phosphodiesterase 10a In Tumor Growth And Doxorubicin-induced Cardiotoxicity.1 passage
• Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension.1 passage
• Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.1 passage
• Activation of γ2-AMPK Suppresses Ribosome Biogenesis and Protects Against Myocardial Ischemia/Reperfusion Injury.1 passage
• Acute Blood Pressure-Lowering Effects of Nitrogen Dioxide Exposure From Domestic Gas Cooking Via Elevation of Plasma Nitrite Concentration in Healthy Individuals.1 passage
• Acute Ischemic Stroke Therapy Overview.1 passage
• Adaptive Response of T and B Cells in Atherosclerosis.1 passage
• Adherence in Hypertension.1 passage
• Adiponectin, Leptin and Cardiovascular Disorders.1 passage
• Adrenergic Ca1 passage
• Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure.1 passage
• Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43.1 passage
• Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.1 passage
• Advances in Echocardiographic Imaging in Heart Failure With Reduced and Preserved Ejection Fraction.1 passage
• Advances in Lymphedema.1 passage
• Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.1 passage
• Advances in Transcriptomics: Investigating Cardiovascular Disease at Unprecedented Resolution.1 passage
• Adventitial CXCL1/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture.1 passage
• Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors.1 passage
• Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm.1 passage
• Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.1 passage
• Aggregation of Child Cardiac Progenitor Cells Into Spheres Activates Notch Signaling and Improves Treatment of Right Ventricular Heart Failure.1 passage
• Aging and Autophagy in the Heart.1 passage
• Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (1 passage
• Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression.1 passage
• Alternative Splicing of1 passage
• An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation.1 passage
• An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.1 passage
• Angiogenic Mechanisms of Human CD341 passage
• Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.1 passage
• Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.1 passage
• Animal Models of Atrial Fibrillation.1 passage
• Anthracycline and Peripartum Cardiomyopathies.1 passage
• Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.1 passage
• Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.1 passage
• Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis1 passage
• Antithrombotic Agents.1 passage
• Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation.1 passage
• Application of PCSK9 Inhibitors in Practice.1 passage
• Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?1 passage
• Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?1 passage
• Arrhythmogenic Cardiomyopathy.1 passage
• Arterial Stiffness Preceding Diabetes: A Longitudinal Study.1 passage
• Arterial Stiffness and Cardiovascular Risk in Hypertension.1 passage
• Artificial Intelligence in Hypertension: Seeing Through a Glass Darkly.1 passage
• Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.1 passage
• Association Between Atrial Fibrillation and Sudden Cardiac Death: Pathophysiological and Epidemiological Insights.1 passage
• Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.1 passage
• Association of Habitual Physical Activity With Cardiovascular Disease Risk.1 passage
• Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.1 passage
• Association of MicroRNAs and YRNAs With Platelet Function.1 passage
• Association of Plasma 7-Ketocholesterol With Cardiovascular Outcomes and Total Mortality in Patients With Coronary Artery Disease.1 passage
• Association of Serum Retinoic Acid With Risk of Mortality in Patients With Coronary Artery Disease.1 passage
• Associations of Endogenous Estradiol and Testosterone Levels With Plaque Composition and Risk of Stroke in Subjects With Carotid Atherosclerosis.1 passage
• Associations of Monounsaturated Fatty Acids From Plant and Animal Sources With Total and Cause-Specific Mortality in Two US Prospective Cohort Studies.1 passage
• Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation.1 passage
• Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.1 passage
• Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.1 passage
• Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.1 passage
• Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation.1 passage
• Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.1 passage
• Autophagy and Mitophagy in Cardiovascular Disease.1 passage
• Autophagy in Cardiovascular Aging.1 passage
• Autophagy in vascular disease.1 passage
• B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.1 passage
• B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?1 passage
• BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.1 passage
• BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.1 passage
• BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.1 passage
• Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.1 passage
• Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction.1 passage
• Basic Cardiovascular Sciences Scientific Sessions 2020: Emerging Opportunities in Cardiovascular Diseases.1 passage
• Basic Mechanisms of Diabetic Heart Disease.1 passage
• Basic and Therapeutic Aspects of Angiogenesis Updated.1 passage
• Beet the Best?1 passage
• Bench-to-Bedside in Vascular Medicine: Optimizing the Translational Pipeline for Patients With Peripheral Artery Disease.1 passage
• Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease.1 passage
• Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.1 passage
• Bioengineering Human Myocardium on Native Extracellular Matrix.1 passage
• Biomedical Informatics on the Cloud: A Treasure Hunt for Advancing Cardiovascular Medicine.1 passage
• Bioresorbable Scaffold: The Emerging Reality and Future Directions.1 passage
• Blood Pressure Measurement and Treatment Decisions.1 passage
• Body Mass Index Drives Changes in DNA Methylation: A Longitudinal Study.1 passage
• Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency.1 passage
• Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.1 passage
• Brain Damage With Heart Failure: Cardiac Biomarker Alterations and Gray Matter Decline.1 passage
• Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.1 passage
• Brain-Heart Interaction: Cardiac Complications After Stroke.1 passage
• Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.1 passage
• C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.1 passage
• C1q/TNF-α-Related Protein 1 (CTRP1) Maintains Blood Pressure Under Dehydration Conditions.1 passage
• CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.1 passage
• CD31 as a Therapeutic Target in Atherosclerosis.1 passage
• CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia.1 passage
• CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.1 passage
• CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute Stroke.1 passage
• CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.1 passage
• CLIC4/Arf6 Pathway.1 passage
• COVID-19 and Cardiovascular Disease: From Bench to Bedside.1 passage
• COVID-19 and the Heart.1 passage
• CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.1 passage
• CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.1 passage
• CaMKIIδC Drives Early Adaptive Ca1 passage
• Calcium Signaling and Cardiac Arrhythmias.1 passage
• Calcium Signaling and Reactive Oxygen Species in Mitochondria.1 passage
• Calcium Signaling and Transcriptional Regulation in Cardiomyocytes.1 passage
• Calcium and Excitation-Contraction Coupling in the Heart.1 passage
• Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.1 passage
• Can We Engineer a Human Cardiac Patch for Therapy?1 passage
• Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.1 passage
• Cardiac Fibrosis: The Fibroblast Awakens.1 passage
• Cardiac Implantable Electronic Device Therapy in Heart Failure.1 passage
• Cardiac Kir2.1 and Na1 passage
• Cardiac Mechano-Gated Ion Channels and Arrhythmias.1 passage
• Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium.1 passage
• Cardiac Regeneration: Lessons From Development.1 passage
• Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration.1 passage
• Cardiac arrest: resuscitation and reperfusion.1 passage
• Cardiac c-Kit Biology Revealed by Inducible Transgenesis.1 passage
• Cardiac innervation and sudden cardiac death.1 passage
• Cardiac nonmyocytes in the hub of cardiac hypertrophy.1 passage
• Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.1 passage
• Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.1 passage
• Cardioembolic Stroke.1 passage
• Cardiomyocyte Maturation: New Phase in Development.1 passage
• Cardiomyopathies Due to Left Ventricular Noncompaction, Mitochondrial and Storage Diseases, and Inborn Errors of Metabolism.1 passage
• Cardiomyopathies: An Overview.1 passage
• Cardiovascular Disease in Women: Clinical Perspectives.1 passage
• Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.1 passage
• Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis.1 passage
• Cardiovascular Metabolomics.1 passage
• Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 1: Who We Are.1 passage
• Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 2: What We Do.1 passage
• Career Development of Young Physician-Scientists in the Cardiovascular Sciences: Perspective and Advice From the Early Career Committee of the Cardiopulmonary, Critical Care, and Resuscitation Council of the American Heart Association.1 passage
• Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells.1 passage
• Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo.1 passage
• Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3.1 passage
• Cell Therapy Trials in Congenital Heart Disease.1 passage
• Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.1 passage
• Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm.1 passage
• Cellular Mechanisms of Aortic Aneurysm Formation.1 passage
• Cellular origin and developmental program of coronary angiogenesis.1 passage
• Cerebral Cavernous Malformation: From Mechanism to Therapy.1 passage
• Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.1 passage
• Cerebrovascular Anomalies: Perspectives From Immunology and Cerebrospinal Fluid Flow.1 passage
• Changing Landscape of Congenital Heart Disease.1 passage
• Cholesterol-Lowering Agents.2 passages
• Chromatin Accessibility of Human Mitral Valves and Functional Assessment of MVP Risk Loci.1 passage
• Chronic Heart Failure and Inflammation: What Do We Really Know?1 passage
• Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation.1 passage
• Chronobiological Influence Over Cardiovascular Function: The Good, the Bad, and the Ugly.1 passage
• Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function.1 passage
• Circadian Influence on Metabolism and Inflammation in Atherosclerosis.1 passage
• Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.1 passage
• Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.1 passage
• Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.1 passage
• Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.1 passage
• Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.1 passage
• Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.1 passage
• Circulating Progenitor Cells and Racial Differences.1 passage
• Circulating Th17 and Th22 Cells Are Associated With CMR Imaging Biosignatures of Diffuse Myocardial Interstitial Remodeling in Chronic Coronary Artery Disease.1 passage
• Citation impact of NHLBI R01 grants funded through the American Recovery and Reinvestment Act as compared to R01 grants funded through a standard payline.1 passage
• Classification, Epidemiology, and Global Burden of Cardiomyopathies.1 passage
• Clinical Relevance and Role of Neuronal AT1 passage
• Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions.1 passage
• Clinical management and prevention of sudden cardiac death.1 passage
• Clinical value of ambulatory blood pressure: evidence and limits.1 passage
• Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.1 passage
• Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial.1 passage
• Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction.1 passage
• Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.1 passage
• Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries.1 passage
• Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.1 passage
• Comparison of the Impact Factors of the Most-Cited Cardiovascular Journals.1 passage
• Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.1 passage
• Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy.1 passage
• Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.1 passage
• Contemporary Medical Management of Peripheral Artery Disease.1 passage
• Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein.1 passage
• Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.1 passage
• Contribution of K1 passage
• Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels.1 passage
• Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.1 passage
• Coronary Disease-Associated Gene1 passage
• Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size.1 passage
• Correction to: Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.1 passage
• Coupling of Integrin α5 to Annexin A2 by Flow Drives Endothelial Activation.1 passage
• Critical Issues for the Translation of Cardioprotection.1 passage
• Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation.1 passage
• Critical Role of Neprilysin in Kidney Angiotensin Metabolism.1 passage
• Cross Talk Pathways Between Coagulation and Inflammation.1 passage
• Cryptogenic Stroke: Research and Practice.1 passage
• Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias.1 passage
• Current State of Cardiovascular Research in Korea.1 passage
• Current Status and Future Potential of Transcatheter Interventions in Congenital Heart Disease.1 passage
• Current Therapeutic Options in Aortic Stenosis.1 passage
• Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.1 passage
• Cytokine-Like 1 Is a Novel Proangiogenic Factor Secreted by and Mediating Functions of Endothelial Progenitor Cells.1 passage
• DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.1 passage
• Danger signaling in atherosclerosis.1 passage
• Deciphering the Epigenetic Code of Cardiac Myocyte Transcription.1 passage
• Decline in Cardiovascular Mortality: Possible Causes and Implications.1 passage
• Deficiency of MMP17/MT4-MMP proteolytic activity predisposes to aortic aneurysm in mice.1 passage
• Defining the Human Envirome: An Omics Approach for Assessing the Environmental Risk of Cardiovascular Disease.1 passage
• Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.1 passage
• Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes.1 passage
• Deregulated TGF-β/BMP Signaling in Vascular Malformations.1 passage
• Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure.1 passage
• Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies.1 passage
• Development and Validation of A Long-Term Incident Heart Failure Risk Model.1 passage
• Device Therapy of Hypertension.1 passage
• Device-Based Neuromodulation for Resistant Hypertension Therapy.1 passage
• Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.1 passage
• Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.1 passage
• Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.1 passage
• Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction.1 passage
• Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.1 passage
• Dietary Fats in Relation to Total and Cause-Specific Mortality in a Prospective Cohort of 521 120 Individuals With 16 Years of Follow-Up.1 passage
• Dietary Interventions, Cardiovascular Aging, and Disease: Animal Models and Human Studies.1 passage
• Dietary Restrictions and Nutrition in the Prevention and Treatment of Cardiovascular Disease.1 passage
• Differential miRNA Loading Underpins Dual Harmful and Protective Roles for Extracellular Vesicles in Atherogenesis.1 passage
• Differential role of an NF-κB transcriptional response element in endothelial versus intimal cell VCAM-1 expression.1 passage
• Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.1 passage
• Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2.1 passage
• Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.1 passage
• Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.1 passage
• Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.1 passage
• Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.1 passage
• Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.1 passage
• Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity? Clues From Laboratory Models and Clinical Trials.1 passage
• Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression.1 passage
• Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).1 passage
• Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection.1 passage
• Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality: Prospective Cohort Study.1 passage
• Dynamin-Related Protein 1 Inhibition Attenuates Cardiovascular Calcification in the Presence of Oxidative Stress.1 passage
• EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.1 passage
• Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.1 passage
• Effects of DNA damage in smooth muscle cells in atherosclerosis.1 passage
• Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study.1 passage
• Effects of Repetitive Transendocardial CD341 passage
• Effects of Transendocardial Delivery of Bone Marrow-Derived CD1331 passage
• Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9.1 passage
• Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.1 passage
• Elixir of Life: Thwarting Aging With Regenerative Reprogramming.1 passage
• Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.1 passage
• Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.1 passage
• Emerging Concepts in Precision Medicine and Cardiovascular Diseases in Racial and Ethnic Minority Populations.1 passage
• Emerging Role of Precision Medicine in Cardiovascular Disease.1 passage
• Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.1 passage
• Emerging Technologies for Identifying Atrial Fibrillation.1 passage
• Emerging Technologies for Pulmonary Vein Isolation.1 passage
• Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps.1 passage
• Endocardial Cell Plasticity in Cardiac Development, Diseases and Regeneration.1 passage
• Endocardial Notch Signaling in Cardiac Development and Disease.1 passage
• Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition.1 passage
• Endogenous Transmembrane TNF-Alpha Protects Against Premature Senescence in Endothelial Colony Forming Cells.1 passage
• Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.1 passage
• Endothelial Actions of ANP Enhance Myocardial Inflammatory Infiltration in the Early Phase After Acute Infarction.1 passage
• Endothelial Cell Development and Its Application to Regenerative Medicine.1 passage
• Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.1 passage
• Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism.1 passage
• Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation.1 passage
• Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.1 passage
• Endothelial Palmitoylation Cycling Coordinates Vessel Remodeling in Peripheral Artery Disease.1 passage
• Endothelial cell metabolism in normal and diseased vasculature.1 passage
• Endothelin-1 Stimulates Vasoconstriction Through Rab11A Serine 177 Phosphorylation.1 passage
• Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation.1 passage
• Endovascular intervention for peripheral artery disease.1 passage
• Engineering Cardiac Muscle Tissue: A Maturating Field of Research.1 passage
• Enhanced CaMKII-Dependent Late I1 passage
• Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.1 passage
• Enhanced Redox State and Efficiency of Glucose Oxidation With miR Based Suppression of Maladaptive NADPH-Dependent Malic Enzyme 1 Expression in Hypertrophied Hearts.1 passage
• Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells.1 passage
• Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.1 passage
• Environmental Determinants of Cardiovascular Disease.1 passage
• Eosinophils Protect Mice From Angiotensin-II Perfusion-Induced Abdominal Aortic Aneurysm.1 passage
• EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling.1 passage
• Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease.1 passage
• Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.1 passage
• Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.1 passage
• Epidemiology of Heart Failure: A Contemporary Perspective.1 passage
• Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.1 passage
• Epidemiology of Peripheral Artery Disease and Polyvascular Disease.1 passage
• Epidemiology of peripheral artery disease.1 passage
• Epigenetic Changes in Diabetes and Cardiovascular Risk.1 passage
• Epigenetic Modifications in Cardiovascular Aging and Diseases.1 passage
• Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation.1 passage
• Epigenetics and metabolism.1 passage
• Epigenomes in Cardiovascular Disease.1 passage
• Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and Phenotype.1 passage
• Epigenomic and Transcriptomic Dynamics During Human Heart Organogenesis.1 passage
• Epigenomics: Technologies and Applications.1 passage
• Epithelial Properties of the Second Heart Field.1 passage
• Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies.1 passage
• Established and Emerging Roles of Biomarkers in Heart Failure.1 passage
• Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.1 passage
• Evolving Treatments for Acute Ischemic Stroke.1 passage
• Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.1 passage
• Exercise and the cardiovascular system: clinical science and cardiovascular outcomes.1 passage
• Exome-Based Case-Control Analysis Highlights the Pathogenic Role of Ciliary Genes in Transposition of the Great Arteries.1 passage
• Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility.1 passage
• Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.1 passage
• Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity.1 passage
• Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients.1 passage
• Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.1 passage
• Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation.1 passage
• Extracellular DNA NET-Works With Dire Consequences for Health.1 passage
• Extracellular Ribonucleic Acids (RNA) Enter the Stage in Cardiovascular Disease.1 passage
• Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair.1 passage
• Extracellular Vesicles in Angiogenesis.1 passage
• Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology.1 passage
• Extracellular Vesicles in Metabolic Syndrome.1 passage
• Extreme Levels of Air Pollution Associated With Changes in Biomarkers of Atherosclerotic Plaque Vulnerability and Thrombogenicity in Healthy Adults.1 passage
• FMD and SCAD: Sex-Biased Arterial Diseases With Clinical and Genetic Pleiotropy.1 passage
• Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice.1 passage
• Fcγ receptors and ligands and cardiovascular disease.1 passage
• Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.1 passage
• Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways.1 passage
• Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion.1 passage
• FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.1 passage
• Fractional Flow Reserve and Coronary Computed Tomographic Angiography: A Review and Critical Analysis.1 passage
• From ATP to PTP and Back: A Dual Function for the Mitochondrial ATP Synthase.1 passage
• From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.1 passage
• From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.1 passage
• From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease.1 passage
• From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues.1 passage
• From Single Myocyte to Whole Heart: The Intricate Dance of Electrophysiology and Modeling.1 passage
• From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.1 passage
• Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis.1 passage
• Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.1 passage
• Functional Recovery of a Human Neonatal Heart After Severe Myocardial Infarction.1 passage
• Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes.1 passage
• Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.1 passage
• Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association.1 passage
• G-CSF for Extensive STEMI.1 passage
• G-Protein-Coupled Receptors in Heart Disease.1 passage
• GJA1-20k Arranges Actin to Guide Cx43 Delivery to Cardiac Intercalated Discs.1 passage
• GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.1 passage
• GRK5 Controls SAP97-Dependent Cardiotoxic β1 passage
• Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.1 passage
• Gene Therapy for Coagulation Disorders.1 passage
• Gene Therapy for the Heart Lessons Learned and Future Perspectives.1 passage
• Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.1 passage
• Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells: Methods, Applications, and Considerations.1 passage
• Genetic Analysis Reveals a Longevity-Associated Protein Modulating Endothelial Function and Angiogenesis.1 passage
• Genetic Basis and Therapies for Vascular Anomalies.1 passage
• Genetic Determinants of Peripheral Artery Disease.1 passage
• Genetic Dissection of a Super Enhancer Controlling the1 passage
• Genetic Fate Mapping Defines the Vascular Potential of Endocardial Cells in the Adult Heart.1 passage
• Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells.1 passage
• Genetic and Developmental Contributors to Aortic Stenosis.1 passage
• Genetic and molecular aspects of hypertension.1 passage
• Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.1 passage
• Genetics and Genomics of Congenital Heart Disease.1 passage
• Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.1 passage
• Genetics of Coronary Artery Disease.1 passage
• Genetics of Human Longevity Within an Eco-Evolutionary Nature-Nurture Framework.1 passage
• Genetics of Thoracic and Abdominal Aortic Diseases.1 passage
• Genetics of sudden cardiac death.1 passage
• Genome-Wide Analysis Identifies an Essential Human TBX3 Pacemaker Enhancer.1 passage
• Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome.1 passage
• Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.1 passage
• Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression.1 passage
• Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.1 passage
• Getting to the Heart of Alzheimer Disease.1 passage
• Getting to the heart of the matter: new insights into cardiac fibrosis.1 passage
• Global Burden of Stroke.1 passage
• Global Burden of Thrombosis: Epidemiologic Aspects.1 passage
• Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.1 passage
• Global Reach 2018 Heightened α-Adrenergic Signaling Impairs Endothelial Function During Chronic Exposure to Hypobaric Hypoxia.1 passage
• Glucocorticoids Regulate Bone Marrow B Lymphopoiesis After Stroke.1 passage
• Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis.1 passage
• GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.1 passage
• Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts.1 passage
• Guideline-Driven Management of Hypertension: An Evidence-Based Update.1 passage
• Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.1 passage
• Gut Microbiome Associates With Lifetime Cardiovascular Disease Risk Profile Among Bogalusa Heart Study Participants.1 passage
• Gut Microbiota and Cardiovascular Disease.1 passage
• Gut Microbiota in Cardiovascular Health and Disease.1 passage
• Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.1 passage
• HDL and Reverse Cholesterol Transport.1 passage
• HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.1 passage
• HIF hydroxylase pathways in cardiovascular physiology and medicine.1 passage
• HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk.1 passage
• HIV-Nef Protein Transfer to Endothelial Cells Requires Rac1 Activation and Leads to Endothelial Dysfunction Implications for Statin Treatment in HIV Patients.1 passage
• Haptoglobin enhances cardiac transplant rejection.1 passage
• Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative.1 passage
• Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes.1 passage
• Heart Failure With Preserved Ejection Fraction In Perspective.1 passage
• Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.1 passage
• Heart Failure in Pediatric Patients With Congenital Heart Disease.1 passage
• Heart Failure in Type 2 Diabetes Mellitus.1 passage
• Heart-Brain Axis: Effects of Neurologic Injury on Cardiovascular Function.1 passage
• Heart-Breaking Telomeres.1 passage
• Hematopoiesis and Cardiovascular Disease.1 passage
• Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.1 passage
• Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.1 passage
• Heparan Sulfate-Editing Extracellular Sulfatases Enhance VEGF Bioavailability for Ischemic Heart Repair.1 passage
• High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke.1 passage
• High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women.1 passage
• Higher oily fish consumption in late pregnancy is associated with reduced aortic stiffness in the child at age 9 years.1 passage
• Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.1 passage
• How Will Genetics Inform the Clinical Care of Atrial Fibrillation?1 passage
• How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation?1 passage
• How mitochondrial dynamism orchestrates mitophagy.1 passage
• Human Alternative Macrophages Populate Calcified Areas of Atherosclerotic Lesions and Display Impaired RANKL-Induced Osteoclastic Bone Resorption Activity.1 passage
• Human Cardiac Gene Therapy.1 passage
• Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.1 passage
• Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.1 passage
• Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes.1 passage
• Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via1 passage
• Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD.1 passage
• Hyperpolarized 13C Metabolic MRI of the Human Heart: Initial Experience.1 passage
• Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.1 passage
• Hypertension Management in Older and Frail Older Patients.1 passage
• Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies.1 passage
• Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.1 passage
• Hypertension in Low- and Middle-Income Countries.1 passage
• Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.1 passage
• Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?1 passage
• Hypertension: renin-angiotensin-aldosterone system alterations.1 passage
• Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.1 passage
• Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.1 passage
• Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.1 passage
• Hypokalemia Promotes Arrhythmia by Distinct Mechanisms in Atrial and Ventricular Myocytes.1 passage
• IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.1 passage
• Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA.1 passage
• Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes.1 passage
• Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes.1 passage
• Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.1 passage
• Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.1 passage
• Identification of Functional Variant Enhancers Associated With Atrial Fibrillation.1 passage
• Identification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism.1 passage
• Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors.1 passage
• Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.1 passage
• Imaging Atherosclerosis.1 passage
• Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.1 passage
• Immune Cells and Immunotherapy for Cardiac Injury and Repair.1 passage
• Immunity and Inflammation in Atherosclerosis.1 passage
• Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease.1 passage
• Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.1 passage
• Impact of the 2017 ACC/AHA Guideline for High Blood Pressure on Evaluating Gestational Hypertension-Associated Risks for Newborns and Mothers.1 passage
• Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.1 passage
• Impaired Production and Diurnal Regulation of Vascular RvD1 passage
• Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences.1 passage
• Importance of Genetic Studies of Cardiometabolic Disease in Diverse Populations.1 passage
• In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.1 passage
• In Vivo and In Silico Investigation Into Mechanisms of Frequency Dependence of Repolarization Alternans in Human Ventricular Cardiomyocytes.1 passage
• Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.1 passage
• Increased Epicardial Adipose Tissue Volume Correlates With Cardiac Sympathetic Denervation in Patients With Heart Failure.1 passage
• Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).1 passage
• Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.1 passage
• Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.1 passage
• Inflammation and immunity in diseases of the arterial tree: players and layers.1 passage
• Inflammation, Infection and Venous Thromboembolism.1 passage
• Inflammation, immunity, and hypertensive end-organ damage.1 passage
• Inflammatory Cardiomyopathic Syndromes.1 passage
• Inflammatory Disequilibrium in Stroke.1 passage
• Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.1 passage
• Inflammatory and immune responses in the arterial media.1 passage
• Influenza Causes MLKL-Driven Cardiac Proteome Remodeling During Convalescence.1 passage
• Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.1 passage
• Inhibition of KLF5-Myo9b-RhoA Pathway-Mediated Podosome Formation in Macrophages Ameliorates Abdominal Aortic Aneurysm.1 passage
• Initial Outcomes for the NHLBI K99/R00 Pathway to Independence Program in Relation to Long-Standing Career Development Programs: Implications for Trainees, Mentors, and Institutions.1 passage
• Innate Effector-Memory T-Cell Activation Regulates Post-Thrombotic Vein Wall Inflammation and Thrombus Resolution.1 passage
• Innate immunity and the failing heart: the cytokine hypothesis revisited.1 passage
• Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation.1 passage
• Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation.1 passage
• Instantaneous Amplitude and Frequency Modulations Detect the Footprint of Rotational Activity and Reveal Stable Driver Regions as Targets for Persistent Atrial Fibrillation Ablation.1 passage
• Insulin Signaling and Heart Failure.1 passage
• Integrative Genomic Analysis Reveals Four Protein Biomarkers for Platelet Traits.1 passage
• Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation.1 passage
• Interaction of the Joining Region in Junctophilin-2 With the L-Type Ca1 passage
• Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.1 passage
• Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease.1 passage
• Intestinal Flora Modulates Blood Pressure by Regulating the Synthesis of Intestinal-Derived Corticosterone in High Salt-Induced Hypertension.1 passage
• Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.1 passage
• Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial.1 passage
• Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.1 passage
• Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.1 passage
• Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.1 passage
• Investigating the transcriptional control of cardiovascular development.1 passage
• Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.1 passage
• Iron, inflammation, and early death in adults with sickle cell disease.1 passage
• Iron-Deficiency and Estrogen Are Associated With Ischemic Stroke by Up-Regulating Transferrin to Induce Hypercoagulability.1 passage
• Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?1 passage
• Is High Blood Pressure Self-Protection for the Brain?1 passage
• Is Optimism Associated With Healthier Cardiovascular-Related Behavior? Meta-Analyses of 3 Health Behaviors.1 passage
• Ischemic Heart-Derived Small Extracellular Vesicles Impair Adipocyte Function.1 passage
• Isolation of Cardiomyocytes Undergoing Mitosis With Complete Cytokinesis.1 passage
• JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.1 passage
• JNK2, a Newly-Identified SERCA2 Enhancer, Augments an Arrhythmic [Ca1 passage
• KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.1 passage
• Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A1 passage
• LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.1 passage
• LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.1 passage
• LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.1 passage
• Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.1 passage
• Lactate Promotes Synthetic Phenotype in Vascular Smooth Muscle Cells.1 passage
• Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease.1 passage
• Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.1 passage
• Large-Scale Single-Cell RNA-Seq Reveals Molecular Signatures of Heterogeneous Populations of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.1 passage
• Lateral Membrane-Specific MAGUK CASK Down-Regulates NaV1.5 Channel in Cardiac Myocytes.1 passage
• Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.1 passage
• Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).1 passage
• Letter by Cheng et al Regarding Article, "Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality".1 passage
• Letter by Choi and Kwak Regarding Article, "Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease".1 passage
• Letter by Cicero et al Regarding Article, "Long-Term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later-Life Body Size and Blood Pressure: The Bogalusa Heart Study".1 passage
• Letter by Gagat and Grzanka Regarding Article, "Neutrophil Activation of Endothelial Cell-Expressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury".1 passage
• Letter by Hüttemann et al Regarding Article, "Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction".1 passage
• Letter by Karlstaedt and Taegtmeyer Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy".1 passage
• Letter by Liu and Yin Regarding Article, "Impact of the 2017 ACC/AHA Guideline for High Blood Pressure on Evaluating Gestational Hypertension-Associated Risks for Newborns and Mothers: A Retrospective Birth Cohort Study".1 passage
• Letter by Loboda et al Regarding Article, "Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis": IL-8 Is Not Present in Murine Genome Hence it Cannot Be Responsible for the Bach1 Effect on Angiogenesis in Mice.1 passage
• Letter by Lou and Zhou Regarding Article, "NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction".1 passage
• Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".1 passage
• Letter by Naranjo et al Regarding Article, "Hemodynamic Support With a Micro-Axial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention".1 passage
• Letter by Olafiranye Regarding Article "Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction: Long-Term Results of the LIPSIA CONDITIONING Trial".1 passage
• Letter by Roberts and Countouris Regarding Article, "Impact of the 2017 ACC/AHA Guideline for High Blood Pressure on Evaluating Gestational Hypertension-Associated Risks for Newborns and Mothers".1 passage
• Letter by Ross Regarding Article, "The Microbiome, Plasma Metabolites, Dietary Habits, and Cardiovascular Risk Unravelling Their Interplay".1 passage
• Letter by Treibel et al Regarding Article, "Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?"1 passage
• Letter by Wang et al Regarding Article, "miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders".1 passage
• Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".1 passage
• Letter by Zhou et al Regarding Article, "Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress".1 passage
• Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity.1 passage
• Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies.1 passage
• Leveraging Machine Learning and Artificial Intelligence to Improve Peripheral Artery Disease Detection, Treatment, and Outcomes.1 passage
• Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.1 passage
• Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.1 passage
• Life-Course Cumulative Burden of Body Mass Index and Blood Pressure on Progression of Left Ventricular Mass and Geometry in Midlife: The Bogalusa Heart Study.1 passage
• Lifestyle effects on hematopoiesis and atherosclerosis.1 passage
• Lipid Droplet Biogenesis and Function in the Endothelium.1 passage
• Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies.1 passage
• Lipid Use and Misuse by the Heart.1 passage
• Lipid-Lowering Agents.1 passage
• Lipids, Apolipoproteins, and the Risk of Parkinson Disease.1 passage
• LncRNA1 passage
• Lncing epigenetic control of transcription to cardiovascular development and disease.1 passage
• Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function.1 passage
• Long Noncoding RNAs in Pathological Cardiac Remodeling.1 passage
• Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.1 passage
• Long noncoding RNAs in cardiovascular diseases.1 passage
• Long-Term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later-Life Body Size and Blood Pressure: The Bogalusa Heart Study.1 passage
• Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet1 passage
• Longterm Exercise-Derived Exosomal miR-342-5p: A Novel Exerkine for Cardioprotection1 passage
• Loss of Endogenously Cycling Adult Cardiomyocytes Worsens Myocardial Function.1 passage
• Loss of Endothelial FTO Antagonizes Obesity-Induced Metabolic and Vascular Dysfunction.1 passage
• Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.1 passage
• Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies.1 passage
• Lymphatic System in Cardiovascular Medicine.1 passage
• MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.1 passage
• MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo.1 passage
• Machine Learned Cellular Phenotypes in Cardiomyopathy Predict Sudden Death.1 passage
• Machine Learning in Arrhythmia and Electrophysiology.1 passage
• Macromolecular Degradation Systems and Cardiovascular Aging.1 passage
• Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak21 passage
• Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis.1 passage
• Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.1 passage
• Macrophage Phenotype and Function in Different Stages of Atherosclerosis.1 passage
• Macrophages and Dendritic Cells: Partners in Atherogenesis.1 passage
• Maintaining ancient organelles: mitochondrial biogenesis and maturation.1 passage
• Management of Myocarditis-Related Cardiomyopathy in Adults.1 passage
• Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice.1 passage
• Matching taxpayer funding to population health needs.1 passage
• Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.1 passage
• Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.1 passage
• Mechanical Forces Reshape Differentiation Cues That Guide Cardiomyogenesis.1 passage
• Mechanisms and Models in Heart Failure: A Translational Approach.1 passage
• Mechanisms of Cardiac Repair and Regeneration.1 passage
• Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.1 passage
• Mechanisms of Connexin-Related Lymphedema.1 passage
• Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.1 passage
• Mechanisms of Vascular Aging.1 passage
• Mechanisms of sudden cardiac death: oxidants and metabolism.1 passage
• Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.1 passage
• Mechanotransduction in cardiac hypertrophy and failure.1 passage
• Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.1 passage
• Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.1 passage
• Mending a Faltering Heart.1 passage
• MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.1 passage
• Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?1 passage
• Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies.1 passage
• Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: What Can Systematic Reviews Tell Us About Cell Therapies for Ischemic Heart Disease?1 passage
• Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction.1 passage
• Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.1 passage
• Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.1 passage
• Meta-analysis of cell therapy trials for patients with heart failure.1 passage
• Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.1 passage
• Metabolic Inflammation and Insulin Resistance in Obesity.1 passage
• Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.1 passage
• Metabolic Surgery for Hypertension in Patients With Obesity.1 passage
• Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.1 passage
• Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.1 passage
• Metabolomics and Proteomics in Type 2 Diabetes.1 passage
• Methodological Guidelines to Study Extracellular Vesicles.1 passage
• Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation.1 passage
• MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens.1 passage
• MicroRNA Regulation of Atherosclerosis.1 passage
• MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells.1 passage
• MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy.1 passage
• MicroRNA-103/107 Regulate Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury Through Targeting FADD.1 passage
• MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.1 passage
• MicroRNA-145 Regulates the Differentiation of Adipose Stem Cells Toward Microvascular Endothelial Cells and Promotes Angiogenesis.1 passage
• MicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and Elastin.1 passage
• MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue.1 passage
• MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions.1 passage
• MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.1 passage
• MicroRNAs and Cardiac Regeneration.1 passage
• MicroRNAs for Restenosis and Thrombosis After Vascular Injury.1 passage
• Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics.1 passage
• Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential.1 passage
• Microdomain-Specific Modulation of L-Type Calcium Channels Leads to Triggered Ventricular Arrhythmia in Heart Failure.1 passage
• Microdomains, Inflammation, and Atherosclerosis.1 passage
• Mildly Abnormal Lipid Levels, but Not High Lipid Variability, Are Associated With Increased Risk of Myocardial Infarction and Stroke in "Statin-Naive" Young Population A Nationwide Cohort Study.1 passage
• Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.1 passage
• Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells.1 passage
• Mitochondrial Complex IV Subunit 4 Isoform 2 Is Essential for Acute Pulmonary Oxygen Sensing.1 passage
• Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.1 passage
• Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses.1 passage
• Mitochondrial Metabolism in Aging Heart.1 passage
• Mitochondrial Oxidative Stress Reduces the Immunopotency of Mesenchymal Stromal Cells in Adults With Coronary Artery Disease.1 passage
• Mitochondrial Protein Poldip2 (Polymerase Delta Interacting Protein 2) Controls Vascular Smooth Muscle Differentiated Phenotype by O-Linked GlcNAc (N-Acetylglucosamine) Transferase-Dependent Inhibition of a Ubiquitin Proteasome System.1 passage
• Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.1 passage
• Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy.1 passage
• Modern Imaging Techniques in Cardiomyopathies.1 passage
• Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.1 passage
• Modulating the vascular response to limb ischemia: angiogenic and cell therapies.1 passage
• Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.1 passage
• Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.1 passage
• Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.1 passage
• Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.1 passage
• Molecular controls of arterial morphogenesis.1 passage
• Molecular mechanisms of autophagy in the cardiovascular system.1 passage
• Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart.1 passage
• Molecular regulation of cardiomyocyte differentiation.1 passage
• Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.1 passage
• More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair.1 passage
• Mouse Models to Disentangle the Hallmarks of Human Aging.1 passage
• Moving Forwards by Blocking Back-Flow: The Yin and Yang of MI Therapy.1 passage
• Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.1 passage
• Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.1 passage
• Multifunctional Mitochondrial Epac1 Controls Myocardial Cell Death.1 passage
• Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.1 passage
• Multimodal Regulation of Cardiac Myocyte Proliferation.1 passage
• Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.1 passage
• Mutations in1 passage
• Mutual Regulation of Epicardial Adipose Tissue and Myocardial Redox State by PPAR-γ/Adiponectin Signalling.1 passage
• Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.1 passage
• Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling.1 passage
• Myocardial Ischemia: Lack of Coronary Blood Flow or Myocardial Oxygen Supply/Demand Imbalance?1 passage
• Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.1 passage
• Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia.1 passage
• Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients.1 passage
• Myocarditis.1 passage
• Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation.1 passage
• Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.1 passage
• NAADP/SERCA3-Dependent Ca1 passage
• NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.1 passage
• NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.1 passage
• NSun2 Deficiency Protects Endothelium From Inflammation via mRNA Methylation of ICAM-1.1 passage
• Network Analysis to Risk Stratify Patients With Exercise Intolerance.1 passage
• Neurodevelopmental Abnormalities and Congenital Heart Disease: Insights Into Altered Brain Maturation.1 passage
• Neurovascular and Cognitive Dysfunction in Hypertension.1 passage
• Neutrophil Activation of Endothelial Cell-Expressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury.1 passage
• Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.1 passage
• Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis.1 passage
• New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease.1 passage
• New Insights Into the Role of mTOR Signaling in the Cardiovascular System.1 passage
• New Management Strategies in Heart Failure.1 passage
• New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications.1 passage
• New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.1 passage
• New approaches in the treatment of hypertension.1 passage
• Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages.1 passage
• Nicotinamide Phosphoribosyltransferase in Smooth Muscle Cells Maintains Genome Integrity, Resists Aortic Medial Degeneration, and Is Suppressed in Human Thoracic Aortic Aneurysm Disease.1 passage
• Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.1 passage
• Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia.1 passage
• Noncoding RNAs in Vascular Diseases.1 passage
• Noninvasive Imaging in Adult Congenital Heart Disease.1 passage
• Noninvasive In Vivo Assessment of Cardiac Metabolism in the Healthy and Diabetic Human Heart Using Hyperpolarized1 passage
• Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.1 passage
• Novel Insights Into the Mechanisms Regulating Pro-Atrial Natriuretic Peptide Cleavage in the Heart and Blood Pressure Regulation: Proprotein Convertase Subtilisin/Kexin 6 Is the Corin Activating Enzyme.1 passage
• Novel Methods for Quantification of Vasodepression and Cardioinhibition During Tilt-Induced Vasovagal Syncope.1 passage
• Novel Risk Markers and Risk Assessments for Cardiovascular Disease.1 passage
• Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.1 passage
• Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.1 passage
• Nut Consumption in Relation to Cardiovascular Disease Incidence and Mortality Among Patients With Diabetes Mellitus.1 passage
• Nutrition, Thrombosis, and Cardiovascular Disease.1 passage
• ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4.1 passage
• ORP4L Facilitates Macrophage Survival via G-Protein-Coupled Signaling: ORP4L-/- Mice Display a Reduction of Atherosclerosis.1 passage
• Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.1 passage
• Obesity and Cardiovascular Disease.1 passage
• Obesity, Adipose Tissue and Vascular Dysfunction.1 passage
• Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.1 passage
• Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.1 passage
• Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.1 passage
• Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.1 passage
• Omics of Blood Pressure and Hypertension.1 passage
• Open and Endovascular Management of Aortic Aneurysms.1 passage
• Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.1 passage
• Optimized Treatment of ST-Elevation Myocardial Infarction.1 passage
• Origin of cardiomyocytes in the adult heart.1 passage
• Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.1 passage
• Oxidative Stress Contributes to Microvascular Endothelial Dysfunction in Men and Women With Major Depressive Disorder.1 passage
• P2Y1 passage
• PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome.1 passage
• PCSK9 Association With Lipoprotein(a).1 passage
• PCSK9: From Basic Science Discoveries to Clinical Trials.1 passage
• PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly.1 passage
• PI3K and Calcium Signaling in Cardiovascular Disease.1 passage
• PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.1 passage
• PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR1 passage
• Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.1 passage
• Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.1 passage
• Paracrine Signals Modulate Atrial Epicardial Progenitor Cells and Development of Subepicardial Adiposity and Fibrosis Implications for Atrial Fibrillation.1 passage
• Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells: A Transformative Strategy for Cardiac Stem Cell Therapeutics.1 passage
• Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.1 passage
• Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture.1 passage
• Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease.1 passage
• Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.1 passage
• Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.1 passage
• Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.1 passage
• Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.1 passage
• Pediatric Cardiomyopathies.1 passage
• Peer Review Practices for Evaluating Biomedical Research Grants: A Scientific Statement From the American Heart Association.1 passage
• Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?1 passage
• Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.1 passage
• Peripheral Vasoconstriction During Mental Stress and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease.1 passage
• Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine.1 passage
• Pharmacokinetics and Pharmacodynamics of Inorganic Nitrate in Heart Failure With Preserved Ejection Fraction.1 passage
• Pharmacologic Management of Aneurysms.1 passage
• Pharmacological Strategies to Retard Cardiovascular Aging.1 passage
• Pharmacological treatment and current management of peripheral artery disease.1 passage
• Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.1 passage
• Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.1 passage
• Physiological Biomimetic Culture System for Pig and Human Heart Slices.1 passage
• Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.1 passage
• Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.1 passage
• Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.1 passage
• Platelet-Mediated Thrombosis: From Bench to Bedside.1 passage
• Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.1 passage
• Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation.1 passage
• Pleiotropic Effects of Statins on the Cardiovascular System.1 passage
• Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.1 passage
• Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.1 passage
• Polyploidy in Cardiomyocytes: Roadblock to Heart Regeneration?1 passage
• Population-Based Screening for Atrial Fibrillation.1 passage
• Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.1 passage
• PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.1 passage
• Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way.1 passage
• Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association.1 passage
• Preclinical Studies of Stem Cell Therapy for Heart Disease.1 passage
• Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease.1 passage
• Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation.1 passage
• Predicting Productivity Returns on Investment: Thirty Years of Peer Review, Grant Funding, and Publication of Highly Cited Papers at the National Heart, Lung, and Blood Institute.1 passage
• Preeclampsia: Pathophysiology, Challenges, and Perspectives1 passage
• Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.1 passage
• Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease: Anatomy, Physiology, or Morphology?1 passage
• Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure.1 passage
• Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.1 passage
• Propentdyopents as Heme Degradation Intermediates Constrict Mouse Cerebral Arterioles and Are Present in the Cerebrospinal Fluid of Patients With Subarachnoid Hemorrhage.1 passage
• Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality.1 passage
• Proteasome-Dependent Regulation of Distinct Metabolic States During Long-Term Culture of Human iPSC-Derived Cardiomyocytes.1 passage
• Protective Role of RNA Helicase DEAD-Box Protein 5 in Smooth Muscle Cell Proliferation and Vascular Remodeling.1 passage
• Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice.1 passage
• Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.1 passage
• Protein Phosphatase 2A Regulates Cardiac Na1 passage
• Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.1 passage
• Proteotoxicity and cardiac dysfunction.1 passage
• Proton Pump Inhibitors Accelerate Endothelial Senescence.1 passage
• Purinergic Signaling in the Cardiovascular System.1 passage
• RBM20 Regulates Circular RNA Production From the Titin Gene.1 passage
• RNA Splicing: Regulation and Dysregulation in the Heart.1 passage
• RNA Therapeutics in Cardiovascular Disease.1 passage
• RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.1 passage
• RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.1 passage
• Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.1 passage
• Racial and Ethnic Disparities in Peripheral Artery Disease.1 passage
• Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.1 passage
• Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction.1 passage
• Rasip1-Mediated Rho GTPase Signaling Regulates Blood Vessel Tubulogenesis via Nonmuscle Myosin II.1 passage
• Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).1 passage
• Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit1 passage
• Reactivation of the Epicardium at the Origin of Myocardial Fibro-Fatty Infiltration During the Atrial Cardiomyopathy.1 passage
• Reactive Oxygen Species in Metabolic and Inflammatory Signaling.1 passage
• Reactive Oxygen-Forming Nox5 Links Vascular Smooth Muscle Cell Phenotypic Switching and Extracellular Vesicle-Mediated Vascular Calcification.1 passage
• Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis.1 passage
• Readers, writers, and erasers: chromatin as the whiteboard of heart disease.1 passage
• Reassessing the Mechanisms of Acute Coronary Syndromes.1 passage
• Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products.1 passage
• Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation.1 passage
• Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a).1 passage
• Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.1 passage
• Reducing Cardiovascular Disparities Through Community-Engaged Implementation Research: A National Heart, Lung, and Blood Institute Workshop Report.1 passage
• Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.1 passage
• Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease.1 passage
• Regulated necrotic cell death: the passive aggressive side of Bax and Bak.1 passage
• Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists.1 passage
• Regulation of signal transduction by reactive oxygen species in the cardiovascular system.1 passage
• Reimagining What We Measure in Atherosclerosis-a "Phenotype Stack".1 passage
• Relationship Between Serum Alpha-Tocopherol and Overall and Cause-Specific Mortality.1 passage
• Relationship Between the Efficacy of Cardiac Cell Therapy and the Inhibition of Differentiation of Human iPSC-Derived Nonmyocyte Cardiac Cells Into Myofibroblast-Like Cells.1 passage
• Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk.1 passage
• Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality.1 passage
• Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction.1 passage
• Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.1 passage
• Reproducibility in science: improving the standard for basic and preclinical research.1 passage
• Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.1 passage
• Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.1 passage
• Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.1 passage
• Response Gene to Complement 32 Maintains Blood Pressure Homeostasis by Regulating α-Adrenergic Receptor Expression.1 passage
• Response by Chang et al to Letter Regarding Article, "Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality".1 passage
• Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".1 passage
• Response by Danser and van den Meiracker to Letter by Zhou and Zhou Regarding Article, "Hypertension: Renin-Angiotensin-Aldosterone System Alterations".1 passage
• Response by Dikalova and Dikalov to Letter Regarding Article, "Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress".1 passage
• Response by Dunham-Snary and Archer to Letter Regarding Article, "Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction".1 passage
• Response by Flaherty to Letter Regarding Article, "Hemodynamic Support With a Micro-Axial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention".1 passage
• Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".1 passage
• Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".1 passage
• Response by Hu et al to Letter Regarding Article, "Impact of the 2017 ACC/AHA Guideline for High Blood Pressure on Evaluating Gestational Hypertension-Associated Risks for Newborns and Mothers: A Retrospective Birth Cohort Study".1 passage
• Response by Joo et al to Letter Regarding Article, "High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women".1 passage
• Response by Ling to Letter Regarding Article, "Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease".1 passage
• Response by Ma et al to Letter Regarding Article, "miRNA-Mediated Suppression of a Cardioprotective Cardiokine As a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders".1 passage
• Response by Mittal et al to Letter Regarding Article, "Neutrophil Activation of Endothelial Cell-Expressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury".1 passage
• Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1".1 passage
• Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1".1 passage
• Response by Simard et al to Letter Regarding Article, "Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?"1 passage
• Response by Stiermaier and Eitel to Letter Regarding Article, "Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction: Long-Term Results of the LIPSIA CONDITIONING Trial".1 passage
• Response by Towbin and Jefferies to Letter Regarding Article, "Cardiomyopathies Due to Left Ventricular Noncompaction, Mitochondrial and Storage Diseases, and Inborn Errors of Metabolism".1 passage
• Response by Traverse and Garberich to Letter Regarding Article, "NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction".1 passage
• Response by Viswambharan and Kearney to Letter Regarding Article, "Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop".1 passage
• Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".1 passage
• Response by Zhou et al to Letter Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy".1 passage
• Restoring Endothelial Function by Targeting Desert Hedgehog Downstream of Klf2 Improves Critical Limb Ischemia in Adults.1 passage
• Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.1 passage
• Reverse Remodeling With Left Ventricular Assist Devices.1 passage
• Revisiting Cardiac Cellular Composition.1 passage
• RhoA/Rho-Kinase in the Cardiovascular System.1 passage
• Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.1 passage
• Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study.1 passage
• Role of Brown Fat in Lipoprotein Metabolism and Atherosclerosis.1 passage
• Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death.1 passage
• Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle.1 passage
• Role of Noncoding RNAs in the Pathogenesis of Abdominal Aortic Aneurysm.1 passage
• Role of Resident Stem Cells in Vessel Formation and Arteriosclerosis.1 passage
• Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca1 passage
• Role of Thrombospondin-1 in Mechanotransduction and Development of Thoracic Aortic Aneurysm in Mouse and Humans.1 passage
• Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.1 passage
• Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction.1 passage
• Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.1 passage
• Role of mineralocorticoid receptor antagonists in cardiovascular disease.1 passage
• Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.1 passage
• Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.1 passage
• Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases.1 passage
• Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.1 passage
• Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion.1 passage
• Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.1 passage
• Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction.1 passage
• Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.1 passage
• S100A9 Links Inflammation and Repair in Myocardial Infarction.1 passage
• S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction.1 passage
• SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis.1 passage
• SPEG (Striated Muscle Preferentially Expressed Protein Kinase) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity.1 passage
• SPEG Controls Calcium Reuptake Into the Sarcoplasmic Reticulum Through Regulating SERCA2a by Its Second Kinase-Domain.1 passage
• SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.1 passage
• Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.1 passage
• Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).1 passage
• Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.1 passage
• SarcTrack.1 passage
• Sedentary Behavior, Exercise, and Cardiovascular Health.1 passage
• Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.1 passage
• Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop.1 passage
• Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.1 passage
• Self-Maintenance of Cardiac Resident Reparative Macrophages Attenuates Doxorubicin-Induced Cardiomyopathy Through the SR-A1-c-Myc Axis.1 passage
• Sensing Cardiac Electrical Activity With a Cardiac Myocyte--Targeted Optogenetic Voltage Indicator.1 passage
• Serine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification.1 passage
• Serum Beta Carotene and Overall and Cause-Specific Mortality.1 passage
• Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease.1 passage
• Sex as a Biological Variable in Atherosclerosis.1 passage
• Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?1 passage
• Shaping Waves of Bone Morphogenetic Protein Inhibition During Vascular Growth.1 passage
• Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis: The Blood-and-Muscle Model.1 passage
• Single Cell RNA Sequencing in Atherosclerosis Research.1 passage
• Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis.1 passage
• Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension.1 passage
• Sirtuins and NAD1 passage
• Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor.1 passage
• Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.1 passage
• Social Integration and Reduced Risk of Coronary Heart Disease in Women: The Role of Lifestyle Behaviors.1 passage
• Sodium intake and cardiovascular health.1 passage
• Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.1 passage
• Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.1 passage
• Sorting Nexin 10 Mediates Metabolic Reprogramming of Macrophages in Atherosclerosis Through the Lyn-Dependent TFEB Signaling Pathway.1 passage
• Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels.1 passage
• SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling.1 passage
• Speed of Heart Rate Recovery in Response to Orthostatic Challenge.1 passage
• Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells From Type2 Diabetes Patients: Rescue by α-Ketoglutarate and TET-TDG Functional Reactivation.1 passage
• Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.1 passage
• Statin Toxicity.1 passage
• Statistical Methods for Cardiovascular Researchers.1 passage
• Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions.1 passage
• Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.1 passage
• Stimulating Cardiogenesis as a Treatment for Heart Failure.1 passage
• Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.1 passage
• Stress Signaling JNK2 Crosstalk With CaMKII Underlies Enhanced Atrial Arrhythmogenesis.1 passage
• Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.1 passage
• Stroke Caused by Extracranial Disease.1 passage
• Stroke Risk Factors, Genetics, and Prevention.1 passage
• Structural and Functional Characterization of a Na1 passage
• Studies on Hypoxic Pulmonary Vasoconstriction Detect a Novel Role for the Mitochondrial Complex I Subunit Ndufs2 in Controlling Peroxide Generation for Oxygen-Sensing.1 passage
• Sudden cardiac death risk stratification.1 passage
• Surgical intervention for peripheral arterial disease.1 passage
• Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.1 passage
• Sympathetic Innervation Promotes Arterial Fate by Enhancing Endothelial ERK Activity.1 passage
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease.1 passage
• Systems Analysis of Thrombus Formation.1 passage
• Systems Genetics for Mechanistic Discovery in Heart Diseases.1 passage
• T-Cell-Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension.1 passage
• T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review.1 passage
• TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.1 passage
• TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization.1 passage
• THO Complex-Dependent Posttranscriptional Control Contributes to Vascular Smooth Muscle Cell Fate Decision.1 passage
• TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.1 passage
• TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.1 passage
• TNFR2 Stimulation Promotes Mitochondrial Fusion via Stat3- and NF-kB-Dependent Activation of OPA1 Expression.1 passage
• TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.1 passage
• TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction.1 passage
• TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle.1 passage
• TWIST1 Integrates Endothelial Responses to Flow in Vascular Dysfunction and Atherosclerosis.1 passage
• Taking Systems Medicine to Heart.1 passage
• Talin-Dependent Integrin Activation Regulates VE-Cadherin Localization and Endothelial Cell Barrier Function.1 passage
• Targeting Age-Related Pathways in Heart Failure.1 passage
• Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.1 passage
• Targeting miR-423-5p Reverses Exercise Training-Induced HCN4 Channel Remodeling and Sinus Bradycardia.1 passage
• Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.1 passage
• The AMP-Related Kinase (AMPK) Induces Ca1 passage
• The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.1 passage
• The Brugada Syndrome Susceptibility Gene1 passage
• The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.1 passage
• The Control of Diastolic Calcium in the Heart: Basic Mechanisms and Functional Implications.1 passage
• The Coronary Circulation as a Target of Cardioprotection.1 passage
• The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.1 passage
• The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away.1 passage
• The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.1 passage
• The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.1 passage
• The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.1 passage
• The GSK-3 family as therapeutic target for myocardial diseases.1 passage
• The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.1 passage
• The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives.1 passage
• The High Blood Pressure-Malaria Protection Hypothesis.1 passage
• The Human Microcirculation: Regulation of Flow and Beyond.1 passage
• The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling.1 passage
• The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina.1 passage
• The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease.1 passage
• The Malaria-High Blood Pressure Hypothesis.1 passage
• The Mediterranean Diet and Cardiovascular Health.1 passage
• The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.1 passage
• The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.1 passage
• The Noonan Syndrome Gene1 passage
• The Role of DNA Methylation in Cardiovascular Risk and Disease: Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies.1 passage
• The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms.1 passage
• The Role of the Epicardium During Heart Development and Repair.1 passage
• The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.1 passage
• The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia.1 passage
• The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.1 passage
• The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.1 passage
• The Vasculature in Prediabetes.1 passage
• The epidemiology of blood pressure and its worldwide management.1 passage
• The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.1 passage
• The hippo pathway in heart development, regeneration, and diseases.1 passage
• The ins and outs of mitochondrial calcium.1 passage
• The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.1 passage
• The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble.1 passage
• The role of autophagy in vascular biology.1 passage
• The spectrum of epidemiology underlying sudden cardiac death.1 passage
• The structural factor of hypertension: large and small artery alterations.1 passage
• The sympathetic nervous system alterations in human hypertension.1 passage
• The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.1 passage
• Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease.1 passage
• Thermoneutrality but Not UCP1 Deficiency Suppresses Monocyte Mobilization Into Blood.1 passage
• Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.1 passage
• Thromboxane Governs the Differentiation of Adipose-Derived Stromal Cells Toward Endothelial Cells In Vitro and In Vivo.1 passage
• Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study.1 passage
• Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.1 passage
• Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.1 passage
• Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.1 passage
• Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis.1 passage
• Transcathether Valve Replacement and Valve Repair: Review of Procedures and Intraprocedural Echocardiographic Imaging.1 passage
• Transcellular Pathways in Lymphatic Endothelial Cells Regulate Changes in Solute Transport by Fluid Stress.1 passage
• Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus.1 passage
• Transcriptional Patterning of the Ventricular Cardiac Conduction System.1 passage
• Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models.1 passage
• Transdifferentiation Requires iNOS Activation: Role of RING1A S-Nitrosylation.1 passage
• Translational Challenges in Atrial Fibrillation.1 passage
• Translational Implications of Platelets as Vascular First Responders.1 passage
• Translational Research in Cardiovascular Repair: A Call for a Paradigm Shift.1 passage
• Transplantation of Human Umbilical Cord Blood-Derived Cellular Fraction Improves Left Ventricular Function and Remodeling After Myocardial Ischemia/Reperfusion.1 passage
• Treatment of Obesity in Mitigating Metabolic Risk.1 passage
• Treatment of Obesity: Weight Loss and Bariatric Surgery.1 passage
• Treatment of Resistant and Refractory Hypertension.1 passage
• Trials and Tribulations of CETP Inhibitors.1 passage
• Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.1 passage
• Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.1 passage
• Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair.1 passage
• Two-Drug Combinations as First-Step Antihypertensive Treatment.1 passage
• Type 2 Diabetes and Hypertension.1 passage
• Ube2v1 Positively Regulates Protein Aggregation by Modulating Ubiquitin Proteasome System Performance Partially Through K63 Ubiquitination.1 passage
• Uncoupling Caveolae From Intracellular Signaling In Vivo.1 passage
• Unexpected Functional Consequences of the Loss of the Autophagy-Related Conjugation System.1 passage
• Unspliced XBP1 Confers VSMC Homeostasis and Prevents Aortic Aneurysm Formation via FoxO4 Interaction.1 passage
• Unspliced XBP1 Counteracts β-catenin to Inhibit Vascular Calcification.1 passage
• Untangling autophagy measurements: all fluxed up.1 passage
• Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association.1 passage
• Use of Ventricular Assist Devices and Heart Transplantation for Advanced Heart Failure.1 passage
• Use of mesenchymal stem cells for therapy of cardiac disease.1 passage
• VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene Expression.1 passage
• VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis.1 passage
• VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.1 passage
• VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.1 passage
• VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.1 passage
• Vaccination Strategies and Immune Modulation of Atherosclerosis.1 passage
• Variants of Focal Adhesion Scaffold Genes Cause Thoracic Aortic Aneurysm.1 passage
• Vascular Cognitive Impairment.1 passage
• Vascular Complications of Diabetes.1 passage
• Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors.1 passage
• Vascular Smooth Muscle Cells in Atherosclerosis.1 passage
• Vascular Stress Signaling in Hypertension.1 passage
• Vascular and Lymphatic Malformations: Perspectives From Human and Vertebrate Studies.1 passage
• Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.1 passage
• Vascular wall progenitor cells in health and disease.1 passage
• Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.1 passage
• Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.1 passage
• Walking Exercise Therapy Effects on Lower Extremity Skeletal Muscle in Peripheral Artery Disease.1 passage
• Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.1 passage
• Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.1 passage
• Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.1 passage
• YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.1 passage
• Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of1 passage
• ZO-1 Regulates Intercalated Disc Composition and Atrioventricular Node Conduction.1 passage
• lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.1 passage
• miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases.1 passage
• miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.1 passage
• miR-18a Inhibits BMP4 and HIF-1α Normalizing Brain Arteriovenous Malformations.1 passage
• miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.1 passage
• miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders.1 passage
• tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.1 passage
• β2M Signals Monocytes Through Non-Canonical TGFβ Receptor Signal Transduction.1 passage
• γ-Aminobutyric Acid Is Synthesized and Released by the Endothelium: Potential Implications.1 passage